These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25748273)

  • 1. Routine pre- and post-hematopoietic stem cell transplant computed tomography of the abdomen for detecting invasive fungal infection has limited value.
    Kaste SC; Kaufman RA; Sunkara A; Kang G; Morris C; Leung W; Srinivasan A
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1132-5. PubMed ID: 25748273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.
    Kasow KA; Krueger J; Srivastava DK; Li C; Barfield R; Leung W; Horwitz EM; Madden R; Woodard P; Hussain I; McCarville MB; Handgretinger R; Hale GA
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):490-5. PubMed ID: 19285637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
    Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
    Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
    Dignan FL; Evans SO; Ethell ME; Shaw BE; Davies FE; Dearden CE; Treleaven JG; Riley UB; Morgan GJ; Potter MN
    Bone Marrow Transplant; 2009 Jul; 44(1):51-6. PubMed ID: 19139735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and Adolescents.
    Dandoy CE; Linscott LL; Davies SM; Leach JL; Myers KC; El-Bietar J; Chima RS; Pate A; Nelson A; Wallace G; Wong HR; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2028-32. PubMed ID: 26226408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
    Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
    Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation.
    Guan Q; Blankstein AR; Anjos K; Synova O; Tulloch M; Giftakis A; Yang B; Lambert P; Peng Z; Cuvelier GD; Wall DA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1205-14. PubMed ID: 25963921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study.
    Saglio F; Cena S; Berger M; Quarello P; Boccasavia V; Ferrando F; Pittana L; Bruno B; Fagioli F
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1099-105. PubMed ID: 25708218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
    Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
    Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint.
    Bow EJ
    Mycopathologia; 2009 Dec; 168(6):283-97. PubMed ID: 19343534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
    Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.
    Pilon S; Jedrysiak D; Sheppard D; Bredeson CN; Tay J; Allan DS
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):364-70. PubMed ID: 25445635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.